Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

The practical assessment of compliance with ACE-inhibitor therapy--a novel approach.

MacFadyen RJ, Struthers AD.

J Cardiovasc Pharmacol. 1997 Jan;29(1):119-24.

PMID:
9007680
3.

Concomitant factors of decompensation in chronic heart failure.

Opasich C, Febo O, Riccardi PG, Traversi E, Forni G, Pinna G, Pozzoli M, Riccardi R, Mortara A, Sanarico M, Cobelli F, Tavazzi L.

Am J Cardiol. 1996 Aug 1;78(3):354-7.

PMID:
8759821
5.

The role of neurohormonal activation in chronic heart failure and postmyocardial infarction.

Sigurdsson A, Swedberg K.

Am Heart J. 1996 Jul;132(1 Pt 2 Su):229-34. Review.

PMID:
8677861
6.

Prevention of readmission in elderly patients with congestive heart failure: results of a prospective, randomized pilot study.

Rich MW, Vinson JM, Sperry JC, Shah AS, Spinner LR, Chung MK, Davila-Roman V.

J Gen Intern Med. 1993 Nov;8(11):585-90.

PMID:
8289096
8.

Measurement of plasma angiotensin II.

Morton JJ, Webb DJ.

Clin Sci (Lond). 1985 Apr;68(4):483-4. No abstract available.

PMID:
3971675
9.

Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics.

Belz GG, Kirch W, Kleinbloesem CH.

Clin Pharmacokinet. 1988 Nov;15(5):295-318. Review.

PMID:
2849518
10.

Intra- and inter-individual variation of serum angiotensin converting enzyme: clinical implications.

Fogarty Y, Fraser CG, Browning MC.

Ann Clin Biochem. 1989 Mar;26 ( Pt 2):201-2. No abstract available.

PMID:
2543259
11.
12.
13.

Determinants of angiotensin II generation during converting enzyme inhibition.

Juillerat L, Nussberger J, Ménard J, Mooser V, Christen Y, Waeber B, Graf P, Brunner HR.

Hypertension. 1990 Nov;16(5):564-72.

14.

Enalaprilat in acute myocardial infarction: tolerability and effects on the renin-angiotensin system.

Sigurdsson A, Held P, Andersson G, Swedberg K.

Int J Cardiol. 1991 Oct;33(1):115-24.

PMID:
1657799

Supplemental Content

Support Center